Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
Arrowhead Pharmaceuticals
Robert S Rosenson; Daniel Gaudet; Robert A Hegele; Christie M Ballantyne; Stephen J Nicholls; Kathryn J Lucas; Javier San Martin; Rong Zhou; Ma'an Muhsin; Ting Chang; Jennifer Hellawell; Gerald F Watts; ARCHES-2 Trial Team